Researchers measure drop in cancer detection in Ontario due to COVID-19

Gene-based blood test for melanoma may detect early signs of cancer return

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a recent study led by researchers at NYU Langone Health and its Perlmutter Cancer Center shows.

April 18, 2025

Vol.51 No.15

Drugs & Targets

Exact Sciences launches the Cologuard Plus test for colorectal cancer screening

Exact Sciences Corp. announced the launch of Cologuard Plus, the most accurate noninvasive colorectal cancer screening test reported in studies to date. FDA-approved for average-risk patients 45+ and covered by Medicare, the Cologuard Plus test detects 95% of colorectal cancers at 94% specificity in the U.S. screening population.

April 04, 2025

Vol.51 No.13

Clinical Roundup

Pandemic caused temporary disruptions in CRC screening and minimal impact on diagnosis, two studies show

Two recent studies by researchers from Regenstrief Institute and the Indiana University School of Medicine explore the effect of the pandemic on colorectal cancer screening tests and diagnostic colonoscopies in central Indiana.

March 28, 2025

Vol.51 No.12

In Brief

UVA Health expands breast cancer screening with mobile 3D mammography coach

To expand access to breast cancer screening for patients across Virginia, UVA Health is rolling out a new mobile mammography coach.

February 28, 2025

Vol.51 No.08

Guest Editorial

Our challenge: To find zen in chaos

This column is a love letter of sorts to our field, a recognition of all that we have accomplished and an acknowledgement that we need to find a path forward that supports and empowers the best of what it is to invest in cancer research.

January 31, 2025

Vol.51 No.04

By W. Kimryn Rathmell

NCI study: Prevention and screening saved more lives than treatment in five common cancer types over the past half-century

Over the last 45 years, prevention and screening interventions have made a greater contribution to averting cancer deaths than have improvements in treatment, according to a modeling study led by researchers at NCI.

January 31, 2025

Vol.51 No.04

By Yiqing Wang and Jacquelyn Cobb

Researchers measure drop in cancer detection in Ontario due to COVID-19

YOU MAY BE INTERESTED IN

Gene-based blood test for melanoma may detect early signs of cancer return

Exact Sciences launches the Cologuard Plus test for colorectal cancer screening

Pandemic caused temporary disruptions in CRC screening and minimal impact on diagnosis, two studies show

UVA Health expands breast cancer screening with mobile 3D mammography coach

Our challenge: To find zen in chaos

NCI study: Prevention and screening saved more lives than treatment in five common cancer types over the past half-century

Renew today!

Subscriber content

Never miss an issue!

Login